Most Read Articles
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
6 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Pearl Toh, 3 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

Physical activity promotes longevity

17 Apr 2018

Higher levels of physical activity may help prolong healthy and chronic disease-free years in both men and women, but more in individuals with low than with high occupational status, a study reports.

The study included 34,379 women (mean age 53.2 years) and 8,381 men (mean age 53.6 years) from the Finnish Public Sector study. Self-reported physical activity levels (inactive to vigorously active) were categorized into three occupational statuses at the first observation point. Partial life expectancy (LE) between ages 50–75 years was defined using two health indicators (average follow-up time, 6.8 years): healthy LE based on self-rated health and chronic disease-free LE based on chronic diseases.

Results showed a clear dose–response relationship between higher physical activity levels and increased healthy and chronic disease-free LE in men and women, and within occupational statuses. Compared with inactive men and women, vigorously active individuals lived 6.3 years longer in good health and 2.9 years longer without chronic diseases between ages 50–75 years.

Of note, the beneficial effect of higher levels of physical activity on healthy LE was most pronounced in individuals with low occupation status (eg, maintenance workers and cleaners).

Researchers pointed out that the present data extend the findings that have shown physical activity to be associated with reduced prevalence of chronic diseases and lowered mortality risk in a dose–response manner.

Doing exercises and reducing sedentary time promote healthy ageing, primarily because physical activity improves endurance and strength, prevents falls, and protects against disability, cognitive decline and dementia among older people. [J Physiother 2012;58:145-156; Ageing Res Rev 2013;12:329-338; BMC Public Health 2014;14:510]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
6 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Pearl Toh, 3 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.